A detailed history of Pathstone Holdings, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 62,494 shares of DNA stock, worth $490,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,494
Previous 53,202 17.47%
Holding current value
$490,577
Previous $61,000 67.21%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $2,601 - $10,778
9,292 Added 17.47%
62,494 $20,000
Q1 2024

May 13, 2024

SELL
$1.06 - $1.67 $13,043 - $20,549
-12,305 Reduced 18.78%
53,202 $61,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $82,538 - $117,257
65,507 New
65,507 $110,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.